Cyclacel Pharmaceuticals earnings were -$17.6M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest CYCC earnings report on Jun 30, 2024 announced Q2 2024 earnings of -$3.3M, up 10.6% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, CYCC reported annual earnings of -$22.8M, with 6.3% growth. The next CYCC earnings date is Nov 11, 2024.
Cyclacel Pharmaceuticals Earnings Reports & History FAQ
What were Cyclacel Pharmaceuticals's earnings last quarter?
On CYCC's earnings call on Invalid Date, Cyclacel Pharmaceuticals (NASDAQ: CYCC) reported Q2 2024 earnings per share (EPS) of -$0.72, up 89.04% year over year. Total CYCC earnings for the quarter were -$3.26 million. In the same quarter last year, Cyclacel Pharmaceuticals's earnings per share (EPS) was -$6.57.
When does Cyclacel Pharmaceuticals report earnings?
The next CYCC earnings date is Invalid Date. Add CYCC to your watchlist to be reminded of Cyclacel Pharmaceuticals's next earnings date.
What was CYCC's earnings growth in the past year?
As of Cyclacel Pharmaceuticals's earnings date in Invalid Date, Cyclacel Pharmaceuticals's earnings has grown year over year. CYCC earnings in the past year totalled -$17.61 million.
Is Cyclacel Pharmaceuticals profitable or losing money?
As of the last Cyclacel Pharmaceuticals earnings report, Cyclacel Pharmaceuticals is currently losing money. Cyclacel Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$17.51 million, a 26.34% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.